Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults (NCT05265260) | Clinical Trial Compass
CompletedNot Applicable
Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults
France32 participantsStarted 2022-04-21
Plain-language summary
The aim of this study is to understand how audiometric, cognitive and electrophysiological results relate to sentence recognition score in adults using currently a Nucleus cochlear implant.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult subjects, 18 years or older
* Subjects unilaterally implanted or bilaterally implanted with at least 6 months separating the two cochlear implantations.
* Subjects who have been implanted between January 2016 and December 2021.
* Subjects have received a Nucleus CI: CI512, CI522 or CI532 cochlear implants with non-rotating magnet, or CI600 series equivalent CI612, CI622 and CI632 with rotating magnet and external sound processors CP900 or CP1000 behind-the-ear, or Kanso or Kanso 2 off-the-ear types.
* Subjects who are fluent in French (language used in the questionnaire and speech tests)
* Subjects who are not opposed to participating in the study
* Subjects for who the medical record data is available throughout the defined data search period.
Exclusion Criteria:
* Subjects with single-sided deafness (SSD).
* Subjects who are not affiliated to the French Social Security.
* Subjects who are under legal protection.
What they're measuring
1
Score of the French MBAA2 Sentence Recognition Test in Quiet